文献速递系统性红斑狼疮血管炎

系统性红斑狼疮患者卒中与心肌梗死风险的系统综述与荟萃分析

Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis.
PubMed 文献 · RMD Open · 2020-01-01

该系统综述与荟萃分析纳入26项观察性研究,评估成人SLE患者相比一般人群或健康对照的卒中和心肌梗死风险。结果显示缺血性卒中风险比为2.18,心肌梗死为2.99,复合卒中为2.13,提示SLE患者卒中与心梗风险约为一般人群的2至3倍。

要点

  • SLE患者缺血性卒中风险为一般人群的2.18倍(95%CI 1.78-2.67)。
  • SLE患者心肌梗死风险为一般人群的2.99倍(95%CI 2.34-3.82)。
  • 复合卒中风险比为2.13(95%CI 1.73-2.61),脑出血风险比1.84。

核心结论

  • SLE患者卒中与心肌梗死风险约为一般人群的2至3倍。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE和EMBASE至2020年5月,纳入26项观察性研究(队列和横断面),比较成人SLE患者与一般人群或健康对照的卒中和心梗风险。

主要发现

  • 缺血性卒中合并风险比2.18(95%CI 1.78至2.67;I2 75%)。
  • 脑出血合并风险比1.84(95%CI 1.16至2.90;I2 67%)。
  • 蛛网膜下腔出血合并风险比1.95(95%CI 0.69至5.52;I2 94%)。
  • 复合卒中合并风险比2.13(95%CI 1.73至2.61;I2 88%)。
  • 心肌梗死合并风险比2.99(95%CI 2.34至3.82;I2 85%)。

关键数值与推荐

  • 纳入标准为报告可用于计算合并效应估计的效应量估计的观察性研究。
  • 采用随机效应模型计算合并风险比(RR)和95%CI,用I2检验量化异质性,敏感性分析评估偏倚。
  • 未发现发表偏倚证据,敏感性分析证实结果稳健。

临床怎么用

  • 临床应重视SLE患者卒中和心肌梗死的风险评估与管理。
  • 未来需研究SLE特异性可调控危险因素与卒中/心梗风险的交互作用,以支持预防和治疗策略的开发。

局限性

  • 异质性较高(I2范围67%至94%),可能影响合并估计的可靠性。
  • 蛛网膜下腔出血的合并风险比置信区间宽(0.69至5.52),结果不精确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the risk of stroke and myocardial infarction (MI) in adult patients with systemic lupus erythematosus (SLE) through a systematic review and meta-analysis. METHODS: We searched MEDLINE and EMBASE from inception to May 2020 to identify observational studies (cohort and cross-sectional) that evaluated risk of stroke and MI in adult patients with SLE compared with the general population or healthy controls. Studies were included if they reported effect-size estimates that could be used for calculating pooled-effect estimates. Random-effects models were used to calculate pooled risk ratios (RRs) and 95% CIs for stroke and MI. Heterogeneity quantified by the I2 test and sensitivity analyses assessed bias. RESULTS: In total, 26 studies were included in this meta-analysis: 14, 5 and 7 studies on stroke, MI and both stroke and MI, respectively. The pooled RR for ischaemic stroke was 2.18 (95% CI 1.78 to 2.67; I2 75%), intracerebral haemorrhage 1.84 (95% CI 1.16 to 2.90; I2 67%), subarachnoid haemorrhage 1.95 (95% CI 0.69 to 5.52; I2 94%), composite stroke 2.13 (95% CI 1.73 to 2.61; I2 88%) and MI 2.99 (95% CI 2.34 to 3.82; I2 85%). There was no evidence for publication bias, and sensitivity analyses confirmed the robustness of the results. CONCLUSIONS: Overall, patients with SLE were identified to have a twofold to threefold higher risk of stroke and MI. Future research on the interaction between known SLE-specific modifiable risk factors and risk of stroke and MI to support development of prevention and treatment strategies are needed. PROSPERO REGISTRATION NUMBER: CRD42018098690.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Yazdany J, Pooley N, Langham J, et al. Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis. RMD Open. 2020. PMID: 32900883. doi:10.1136/rmdopen-2020-001247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。